Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: 2021 | 2018 | 2016 | 2015 | 2014
Number of items: 5.

2021

Ruperto, Nicolino, Brunner, Hermine, I, Ramanan, Athimalaipet, V, Horneff, Gerd, Cuttica, Ruben, Henrickson, Michael, Anton, Jordi, Lucica Boteanu, Alina, Calvo Penades, Inmaculada, Minden, Kirsten, Schmeling, Heinrike, Hufnagel, Markus, Weiss, Jennifer E., Pardeo, Manuela, Nanda, Kabita, Roth, Johannes, Rubio-Perez, Nadina, Hsu, Joy C., Wimalasundera, Sunethra, Wells, Chris, Bharucha, Kamal, Douglass, Wendy, Bao, Min, Mallalieu, Navita L., Martini, Alberto, Lovell, Daniel and De Benedetti, Fabrizio (2021). Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis. RHEUMATOLOGY, 60 (10). S. 4568 - 4581. OXFORD: OXFORD UNIV PRESS. ISSN 1462-0332

2018

Brunner, Hermine I., Ruperto, Nicola, Lovell, Daniel J., Horneff, Gerd, Gamir-Gamir, Maria Luz, Hufnagel, Markus, Hsu, Joy, Bao, Min, Douglass, Wendy, Mallalieu, Navita L., Wells, Chris, Mala, Christopher M. and De Benedetti, Fabrizio (2018). Identification of Optimal Subcutaneous Doses of Tocilizumab in Children with Systemic Juvenile Idiopathic Arthritis. Arthritis Rheumatol., 70. HOBOKEN: WILEY. ISSN 2326-5205

2016

Burmester, Gerd R., Rubbert-Roth, Andrea, Cantagrel, Alain, Hall, Stephen, Leszczynski, Piotr, Feldman, Daniel, Rangaraj, Madura J., Roane, Georgia, Ludivico, Charles, Bao, Min, Rowell, Lucy, Davies, Claire and Mysler, Eduardo F. (2016). Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA). Ann. Rheum. Dis., 75 (1). S. 68 - 75. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060

2015

Cividino, Alfred, Rubbert-Roth, Andrea, Cantagrel, Alain, Hall, Stephen, Leszczynski, Piotr, Feldman, Daniel, Rangaraj, Madura, Roane, Georgia, Ludivico, Charles, Mysler, Eduardo, Bennett, Melanie, Rowell, Lucy, Bao, Min and Burmester, Gerd (2015). The Efficacy and Safety of Subcutaneous Tocilizumab Versus Intravenous Tocilizumab in Combination with Traditional DMARDs in Patients with RA at Week 97 (SUMMACTA). J. Rheumatol., 42 (7). S. 1285 - 1286. TORONTO: J RHEUMATOL PUBL CO. ISSN 1499-2752

2014

Burmester, Gerd R., Rubbert-Roth, Andrea, Cantagrel, Alain, Hall, Stephen, Leszczynski, Piotr, Feldman, Daniel, Rangaraj, Madura J., Roane, Georgia, Ludivico, Charles, Lu, Peng, Rowell, Lucy, Bao, Min and Mysler, Eduardo F. (2014). A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumatoid arthritis (SUMMACTA study). Ann. Rheum. Dis., 73 (1). S. 69 - 75. LONDON: BMJ PUBLISHING GROUP. ISSN 1468-2060

This list was generated on Sat Apr 20 12:26:52 2024 CEST.